EyePoint Pharmaceuticals(EYPT) - 2023 Q3 - Quarterly Report
EyePoint Pharmaceuticals(EYPT)2023-11-02 16:00UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q For the transition period from _______ to _______ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 COMMISSION FILE NUMBER 000-51122 For the quarterly period ended September 30, 2023 EyePoint Pharmaceuticals, Inc. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Zip Code) (617) 926-5000 (Registrant's telephone number, including area code) (Fo ...